Skip to main content
. 2020 Oct 19;9(10):bio054056. doi: 10.1242/bio.054056

Fig. 1.

Fig. 1.

Interaction diagram showing docking pose of lopinavir (A), hydroxychloroquine, ribavirin (C), umifenovir (D), ascorbate (E) and remdesivir (F) at the interface of the receptor-binding domain of SARS-CoV2 spike glycoprotein and human ACE2. Docking grid used generated using binding residues at the interface of interaction.